Gene · 432
Papers2,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Long-Term Human Liver Spheroid Model for Assessing Silencing and Durability of GalNAc-Conjugated siRNAs. | Clin Transl Sci | 2026 | 41949334 | PubTator, text mining | PubMed |
| Enzyme-Assisted Synthesis and In Vitro Characterization of Bifunctional PCSK9 Inhibitors. | Chembiochem | 2026 | 41948978 | PubTator, text mining | PubMed |
| Molecular mechanisms of DBDPE-induced spermatogenic disorder: A network toxicology, machine learning, and in vivo experimental validation. | Environ Int | 2026 | 41941847 | PubTator, text mining | PubMed |
| AI-Enhanced Automatic Life Story Structuring for Reminiscence Therapy in Older Adults: Technical Feasibility Study. | JMIR Aging | 2026 | 41941365 | PubTator, text mining | PubMed |
| Hepatocyte-Targeted Cyclic Peptide LYTACs for PCSK9 Degradation and LDL Cholesterol Metabolic Regulation. | ACS Chem Biol | 2026 | 41914859 | PubTator, text mining | PubMed |
| Proteomic profiling and pathway analyses reveal molecular signatures and immune networks in pediatric sepsis. | Inflamm Res | 2026 | 41896381 | PubTator, text mining | PubMed |
| Generation of proliferative hESC-derived grape-clustered hepatocyte organoids with multipolar architecture as regenerative counterpart via synergy of YAP and IGF2 pathways. | Cell Death Dis | 2026 | 41888105 | PubTator, text mining | PubMed |
| Programmable Lipid Functionalization of Nucleic Acid Nanoparticles Modulates Liver Cell-Type Targeting. | ACS Appl Mater Interfaces | 2026 | 41881029 | PubTator, text mining | PubMed |
| Ultrasound-triggered doxorubicin targeted delivery for liver cancer treatment: Reduced toxicity and improved efficacy. | PLoS One | 2026 | 41875121 | PubTator, text mining | PubMed |
| SAMHD1 depletion restricts SARS-CoV-2 infection by suppressing HNF1-dependent ACE2 expression in lung epithelial cells. | PLoS Pathog | 2026 | 41855156 | PubTator, text mining | PubMed |
| Selective fluorination of Fc glycans enhances antibody-mediated effector functions. | Proc Natl Acad Sci U S A | 2026 | 41849397 | PubTator, text mining | PubMed |
| Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease. | J Mater Chem B | 2026 | 41848629 | PubTator, text mining | PubMed |
| The evolution of lipid nanoparticles: Paving the way for next-generation nucleic acid medicines. | Asian J Pharm Sci | 2026 | 41810472 | PubTator, text mining | PubMed |
| Current research on the HIF-2α-EPO-Hb axis in hypoxic environments: from molecular mechanisms to clinical. | Front Med (Lausanne) | 2026 | 41810235 | PubTator, text mining | PubMed |
| A hepatic-ER cascade-targeting probe co-activated by β-Gal and ClO- for monitoring DILI and therapeutic process. | Bioorg Chem | 2026 | 41806604 | PubTator, text mining | PubMed |
| Intramolecular π-π stacking-regulated ROS amplification in water-soluble GalNAc-functionalized tetraphenylethylene photosensitizers for hepatocellular carcinoma. | J Mater Chem B | 2026 | 41804767 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease and Emerging Oligonucleotide Therapies. | Int J Biol Sci | 2026 | 41800240 | PubTator, text mining | PubMed |
| Hypoxia-relieving and glycolysis-disrupting polydopamine nanomedicine for synergistic chemo-photothermal therapy of hepatocellular carcinoma. | Int J Pharm X | 2026 | 41800069 | PubTator, text mining | PubMed |
| GalNAc-conjugated siRNA targeting C/EBPβ reverses metabolic dysfunction and restores liver homeostasis in a murine MASLD model. | Mol Ther Nucleic Acids | 2026 | 41783787 | PubTator, text mining | PubMed |
| Ribosomal Translation and Display Selection of Cyclic Glycopeptides through Genetic Reprogramming. | J Am Chem Soc | 2026 | 41779940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/432/papers?page=3